Chart Expert Says Merck (MRK) Has More Upside – Here’s Why

Group 1 - Merck & Co., Inc. (NYSE:MRK) is identified as a trending stock with significant upside potential, showing a bullish reversal trend according to analyst Carter Worth [1] - The stock has increased approximately 5% over the past 30 days, with expectations of further gains of at least 10 to 15% based on strong price volume correlation [1] - Impax US Sustainable Economy Fund highlights Merck's high Corporate Resilience score and its contributions to a sustainable healthcare system, despite recent stock weakness due to concerns over its drug pipeline and competition from generics [2] Group 2 - The weakness in Merck's stock during Q2 was attributed to market sentiment around healthcare stocks and specific concerns regarding its drug pipeline, particularly Keytruda [2] - While acknowledging Merck's potential, the fund expresses a stronger belief in certain AI stocks for higher returns and limited downside risk [2]